https://drtalk.it/hematology/ruolo-della-mrd-nel-trattamento-del-mieloma-multiplo-elena-zamagni-e-carolina-terragna/ 2022-04-28T12:39:03+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2022/04/01-OK-OK.png https://drtalk.it/hematology/analisi-mutazionale-nella-diagnosi-di-mastocitosi-sistemica-simona-soverini/ 2022-04-28T14:10:22+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2022/04/01-OK.png https://drtalk.it/hematology/approccio-multidisciplinare-e-reti-di-patologia-nel-futuro-della-mastocitosi-sistemica/ 2022-09-26T13:14:27+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2022/09/Approccio_multidisciplinare_e_reti_di_patologia_nel_futuro_della_mastocitosi_sistemica.png https://drtalk.it/hematology/medicina-di-precisone-punto-di-svolta-nellapproccio-alla-mastocitosi-sistemica-francesco-mannelli/ 2022-09-26T13:16:59+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2022/05/podcast-francesco-mannelli.png https://drtalk.it/hematology/algoritmo-di-terapia-del-paziente-anziano-con-mmrr-gabriele-buda/ 2022-10-04T14:36:29+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2022/10/Algoritmo-di-terapia-del-paziente-anziano-con-MMRR.png https://drtalk.it/hematology/pdta-strumento-prezioso-nella-gestione-della-mastocitosi-sistemica/ 2022-10-25T12:28:12+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2022/10/PDTA-strumento-prezioso-nella-gestione-della-mastocitosi-sistemica.png https://drtalk.it/hematology/refrattarieta-a-lenalidomide-con-roberto-mina/ 2022-11-15T09:26:21+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2022/11/refrattarieta-a-lenalidomide-un-supporto-dalle-terapie-di-combinazione.png https://drtalk.it/hematology/ruolo-dellambulatorio-multidisciplinare-nella-mastocitosi-sistemica-stefano-pizzimenti/ 2022-12-22T14:37:34+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2022/12/ruolo-ambulatorio-multidisciplinare-pizzimenti.png https://drtalk.it/hematology/compliance-e-aderenza-terapeutica-nel-mieloma-multiplo-recidivato-o-refrattario-daniele-derudas/ 2023-02-22T10:51:30+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2023/02/Compliance-e-aderenza-terapeutica-nel-mieloma-multiplo-recidivato-o-refrattario.png https://drtalk.it/hematology/vivere-con-la-mastocitosi-sistemica-la-testimonianza-di-giorgia/ 2023-03-17T12:06:46+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2023/03/vivere-con-la-mastocitosi-sistemica-la-testimonianza-di-giorgia.png https://drtalk.it/hematology/insufficienza-renale-nel-mieloma-multiplo-lo-stato-dellarte-donatella-vincelli/ 2023-05-29T14:19:12+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2023/05/Donatella-Vincelli.png https://drtalk.it/hematology/mrd-negativita-nella-stratificazione-prognostica-del-mieloma-multiplo-il-punto-silvia-mangiacavalli/ 2023-09-18T13:33:52+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2023/09/MRD-negativita-nella-stratificazione-prognostica-del-mieloma-multiplo-il-punto-Silvia-Mangiacavalli.png https://drtalk.it/hematology/digital-health-in-oncoematologia-tutti-i-vantaggi-di-rita-alessandro-ferri-e-vittorio-montefusco/ 2023-09-26T10:45:20+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2023/09/Digital-health-in-oncoematologia-tutti-i-vantaggi-di-RITA-Alessandro-Ferri-e-Vittorio-Montefusco.png https://drtalk.it/hematology/insufficienza-renale-nel-mieloma-multiplo-a-che-punto-siamo-alessandro-gozzetti-e-andrea-guarnieri/ 2023-09-26T10:48:29+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2022/09/insufficienza-renale-nel-mieloma-multiplo.png https://drtalk.it/hematology/anomalie-genetiche-nel-mieloma-ad-alto-rischio-unoverview-mattia-dagostino-e-marina-ruggeri/ 2023-09-26T10:49:02+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2022/10/anomalie-genetiche-nel-mieloma-ad-alto-rischio-bg.png.png https://drtalk.it/hematology/il-supporto-psicologico-nel-mieloma-multiplo-una-parte-integrante-del-percorso-di-cura-anna-maria-cafro-e-monica-barichello/ 2023-09-26T10:49:33+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2023/04/Il-supporto-psicologico-nel-mieloma-multiplo-una-parte-integrante-del-percorso-di-cura-Anna-Maria-Cafro-e-Monica-Barichello.png https://drtalk.it/hematology/cll-e-unmet-medical-needs-antonio-cuneo/ 2023-11-27T16:29:20+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2023/10/CLL-e-unmet-medical-needs-Antonio-Cuneo.png https://drtalk.it/hematology/meccanismi-dazione-e-terapia-a-durata-fissa-paolo-sportoletti/ 2023-11-30T10:57:35+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2023/11/Meccanismi-dazione-e-terapia-a-durata-fissa-Paolo-Sportoletti.png https://drtalk.it/hematology/il-ruolo-del-trapianto-nel-mm-renato-scalone/ 2023-11-30T11:12:51+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2023/11/Il-ruolo-del-trapianto-nel-MM-Renato-Scalone.png https://drtalk.it/hematology/meccanismi-di-immunomodulazione-degli-anti-cd38-fabio-malavasi-e-nicola-giuliani/ 2023-12-05T09:48:18+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2023/12/Meccanismi-di-immunomodulazione-degli-anti-CD38-Fabio-Malavasi-e-Nicola-Giuliani.png https://drtalk.it/hematology/impatto-del-mieloma-multiplo-sulla-spesa-sanitaria-gabriele-buda-francesco-saverio-mennini-e-andrea-marcellusi/ 2024-01-11T13:54:33+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2024/01/Impatto-del-mieloma-multiplo-sulla-spesa-sanitaria-Gabriele-Buda-Francesco-Saverio-Mennini-e-Andrea-Marcellusi.png https://drtalk.it/hematology/trattamento-di-prima-linea-nella-leucemia-linfatica-cronica-il-punto-anna-maria-frustaci/ 2024-04-19T13:46:59+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2024/04/03-OK-OK.png https://drtalk.it/hematology/trattamento-di-seconda-linea-della-cll-strategie-terapeutiche-marta-coscia/ 2024-06-25T13:42:41+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2024/06/Trattamento-di-seconda-linea-della-CLL-strategie-terapeutiche-Marta-Coscia.png https://drtalk.it/hematology/gestione-degli-eventi-avversi-nel-trattamento-della-cll-lo-stato-dellarte-andrea-visentin/ 2024-10-31T12:10:27+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2024/07/Gestione-degli-eventi-avversi-nel-trattamento-della-CLL-lo-stato-dellarte-Andrea-Visentin.png https://drtalk.it/hematology/i-trial-clinici-per-la-leucemia-linfatica-cronica-alessandro-sanna/ 2024-10-31T12:11:01+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2024/10/trial-clinici-leucemia-ok.png https://drtalk.it/hematology/jak-inhibitors-nel-trattamento-della-mielofibrosi-lo-stato-dellarte/ 2025-09-25T13:50:41+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2025/09/01-OK-OK.png https://drtalk.it/hematology/unmet-needs-nel-mieloma-multiplo-il-nodo-della-doppia-refrattarieta/ 2025-11-13T09:56:45+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2025/11/02-OK-OK.png https://drtalk.it/hematology/intelligenza-artificiale-in-oncoematologia-prospettive-e-implicazioni-cliniche/ 2025-11-13T11:45:37+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2025/10/della-porta.png https://drtalk.it/hematology/emergenze-in-oncoematologia-protocolli-e-decisioni-time-sensitive/ 2025-11-26T07:34:43+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2025/11/03-OK-OK.png https://drtalk.it/hematology/sequencing-terapeutico-nel-mieloma-multiplo-le-nuove-linee-guida/ 2025-12-03T14:19:58+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2025/12/tumb-440.png https://drtalk.it/hematology/ridefinire-il-rischio-nel-mieloma-multiplo-valore-clinico-delle-alterazioni-citogenetiche/ 2025-12-19T07:30:41+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2025/12/thumb-mieloma-ep3.png https://drtalk.it/hematology/oltre-la-risposta-il-ruolo-della-malattia-minima-residua-nel-mieloma-multiplo/ 2026-02-26T13:58:06+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2026/02/05-oltre-la-risposta-thumb.png https://drtalk.it/hematology/il-burden-dellanemia-nella-mielofibrosi-implicazioni-cliniche-e-qualita-di-vita/ 2026-03-10T11:53:04+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2026/01/Il-burden-dellanemia-nella-mielofibrosi.png https://drtalk.it/hematology/rischio-infettivo-e-strategie-vaccinali-in-oncoematologia/ 2026-03-10T14:59:48+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2026/03/mielofibrosi-e-oltre-ep5-thumb.png https://drtalk.it/hematology/mieloma-multiplo-e-decisioni-terapeutiche-limpatto-degli-indicatori-di-qualita-di-vita/ 2026-03-31T09:59:35+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2026/03/Francesca-Fazio-thumb.png https://drtalk.it/hematology/il-tempo-della-risposta-valore-delladerenza-nel-percorso-terapeutico/ 2026-09-10T09:45:26+00:00 https://drtalk.it/hematology/wp-content/uploads/sites/4/2026/09/PTLD-01_thumb.png